Unknown PHASE2 INTERVENTIONAL 3-arm NCT03138317

Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis

Sponsor: RDO Laboratory

Updated 7 times since 2017 Last updated: May 10, 2017 Started: Jan 2, 2017 Primary completion: May 30, 2018 Completion: May 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03138317, this PHASE2 trial focuses on Osteoarthritis, Knee and remains ongoing. Sponsored by RDO Laboratory, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
May 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting PHASE2
Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RDO Laboratory
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil